Author Archives: Lu Rahman

#Antibodies #Antibody reagents #Assays

Learn how to generate and validate critical antibody reagents

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents join this free event hosted by DDW and supported by Sino Biological. It… Read More

#News

Generating and validating critical antibody reagents

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents view this free event hosted by DDW and supported by Sino Biological. The… Read More

Webinar date:
Brought to you by Sino Biological
#Webinars

#Antibodies #Antibody reagents #Assays #Therapeutics

Generating and validating critical antibody reagents: event

Antibodies are critical reagents applied in multiple biological areas, such as scientific research, therapeutics, and diagnosis. High-quality and reliable antibody reagents are the foundation of good assay performance. To learn more generating and validating critical antibody reagents join this free event hosted by DDW and supported by Sino Biological. It… Read More

#News

#CRISPR #CRISPR screening #CRISPR-Cas9 #Drug discovery

CRISPR-Cas9 screening: a powerful approach to drug discovery

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna… Read More

#News

CRISPR-Cas9 screening: a powerful approach to drug discovery

View this webinar by DDW and supported by Horizon Discovery which examines CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event took  place on 9 June 2022. View the webinar here. Joanna Gawden-Bone, Manager, Cell Based Screening, Horizon… Read More

Webinar date:
Brought to you by Horizon Discovery
#Webinars

#Cancer #Immunotherapy #Oncology

eBook: Insight into the latest oncology innovation

This 26-page DDW eBook, sponsored by The Jackson Laboratory, contains exclusive insight from industry experts on: How machine learning is currently used across different stages of cancer research Accelerating research: the path forward for treating rare cancers Immunotherapy challenges and the tools for research Why combination immunotherapies are one… Read More

#Cancer Research #News

Insight into the latest oncology innovation

This 26-page DDW eBook, sponsored by The Jackson Laboratory, contains exclusive insight from industry experts on: How machine learning is currently used across different stages of cancer research Accelerating research: the path forward for treating rare cancers Immunotherapy challenges and the tools for research Why combination immunotherapies are one… Read More

#DDW eBooks #Intelligence

#Cancer #CAR-T #Cell therapy

Cancer therapy guide available to download

This guide examines how cell and gene therapy transform cancer treatment. While cell therapies like CAR-T are promising cancer treatments, many challenges remain, including improving responses in blood cancers and efficacy in solid tumours. This new cancer therapy guide from 10x Genomics will outline: Cutting-edge single cell and spatial analysis technologies… Read More

#News

Cancer therapy guide 

This guide examines how cell and gene therapy transform cancer treatment. While cell therapies like CAR-T are promising cancer treatments, many challenges remain, including improving responses in blood cancers and efficacy in solid tumours. This new cancer therapy guide from 10x Genomics will outline: Cutting-edge single cell and… Read More

#Intelligence #Resources

The rise of automation in drug discovery

Automation is not just for high-throughput screening anymore. New devices and greater flexibility are transforming what’s possible throughout drug discovery and development. This article was written by Thomas Albanetti, AstraZeneca; Ryan Bernhardt, Biosero; Andrew Smith, AstraZeneca and Kevin Stewart, AstraZeneca for a 28-page DDW eBook, sponsored by Bio-Rad. Download the… Read More

#hidden

What makes a great BioELN: whitepaper

John Conway of 20/15 Visioneers tackles defining What Makes a Great BioELN in this thoughtful and informative industry perspective. What you will learn: The six high-level workflows a great BioELN must include What are the team personas who must get utility from a new BioELN The 3 key qualities necessary… Read More

#Intelligence #Resources

#BioELN

Learn what makes a great BioELN: Whitepaper

John Conway of 20/15 Visioneers tackles defining What Makes a Great BioELN in this thoughtful and informative industry perspective. What you will learn: The six high-level workflows a great BioELN must include What are the team personas who must get utility from a new BioELN The 3 key qualities necessary… Read More

#News

Flow cytometry protocols for extracellular & intracellular targets

Flow cytometry is a high throughput quantitative analysis tool that employs fluorescent-labelled molecules for multi-parametric analysis of millions of individual cells or particles. In biomedical sciences, the flow cytometry assays involve a careful selection of antibodies, fluorochrome labels for detection, and often requires optimisation of protocols for an accurate analysis… Read More

Webinar date:
#Resources

Laboratory research
#Antibodies #Flow Cytometry #Protein targets

Flow cytometry protocols for extracellular & intracellular targets

Flow cytometry is a high throughput quantitative analysis tool that employs fluorescent-labelled molecules for multi-parametric analysis of millions of individual cells or particles. In biomedical sciences, the flow cytometry assays involve a careful selection of antibodies, fluorochrome labels for detection, and often requires optimisation of protocols for an accurate analysis… Read More

#App Notes #Intelligence #News

#Antimicrobials #Bioconvergence #Drug development #Immunology / Virology & Vaccines #mRNA

Bioconvergence: Future trends for biomedicine

Dr. Tom Knapman, Director of Strategic Brand at SCIEX, explains how bioconvergent advances will help to drive key health trends in the coming year. As we move into 2022, we will see more and more advances in bioconvergence – biological, physical, and computing technologies inspired by nature. We expect these… Read More

#Exclusive Content #News #Opinion #Trending News #Trends & Analysis

#AI / data analytics / healthtech / informatics #Electronic Lab Notebooks (ELN)

Collaboration aims to improve scientific data outcomes

TetraScience has collaborated with PerkinElmer’s Informatics business to facilitate faster and better scientific decision-making for customers of PerkinElmer’s Signals Research Suite, a cloud-based, electronic lab notebook and informatics platform. The collaboration With the new collaboration, TetraScience will provide PerkinElmer customers with vendoragnostic, configurable and productised instrument integrations via its Tetra… Read More

#News